Cross-fund · 6 holders
BBIO
BRIDGEBIO PHARMA INC
CUSIP 10806X102
6
Tracked holders
$2.67B
Aggregate value
35,400,630
Shares
6
Active funds
Funds holding BBIO
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $1.29B | 0.02% | +30,632 | +0.2% |
| BlackRock | Institutional | Q1 2026 | $1.06B | 0.02% | -341,772 | -2.3% |
| Citadel | Multi-Strategy | Q1 2026 | $251.8M | 0.04% | +2,133,158 | +169.7% |
| Millennium | Multi-Strategy | Q1 2026 | $47.0M | 0.02% | +596,698 | +1631.0% |
| BridgewaterFEAT | Macro | Q1 2026 | $19.3M | 0.09% | +216,287 | +501.0% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $3.5M | — | +39,600 | +521.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.